Media releases

Novartis Newsroom

Media releases

Select a language: en | de | fr

Select a year: 2008 | 2007

August 27, 2007

Rasilez® receives EU approval, the first major innovation in high blood pressure treatment for more than a decade

August 18, 2007

Reclast® receives US regulatory approval as first and only once-yearly treatment for women with postmenopausal osteoporosis

August 16, 2007

Novartis starts US shipment of Fluvirin® allowing for early influenza vaccination of millions of Americans

August 10, 2007

FDA grants additional six months marketing exclusivity for the high blood pressure medicine Diovan®

August 06, 2007

Novartis concerned Indian court ruling will discourage investments in innovation needed to bring better medicines to patients

July 25, 2007

Tasigna® approved in Switzerland based on impressive efficacy in patients with a form of leukemia no longer responding to Glivec®

July 23, 2007

Novartis completes its fourth share repurchase program

July 20, 2007

New data show Tekturna® and Diovan® used together provide additive blood pressure reductions

July 19, 2007

Exelon® skin patch recommended for European approval, the first use of this new technology to treat patients with Alzheimer's disease

July 19, 2007

‹ 11-20 21-30 31-40 41-50 ›

90 Total results

The information in the press releases on these pages was factually accurate on the date of publication. These press releases remain on Novartis website for historical purposes only. Novartis assumes no duty to update the information to reflect subsequent developments. Readers should not rely upon the information in these pages as current or accurate after their publication dates.

SWX

NYSE

NOVZn

See stock performance

NVS

See stock performance

Event calendar

Find out about upcoming events for shareholders.

View event calendar

Get Novartis Media Releases through RSS

Learn more about RSS

Stay Connected

Receive updates on company news and announcements.